IXJ News Alert S&P Global Healthcare Ishares (IXJ) 104.21 02/14/2015

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
S&P Global Healthcare Ishares (IXJ) 104.21 $IXJ

Profiling Health Care ETFs - Why Medicine Is The Best Medicine
Aaron Barton - at Seeking Alpha - Thu Feb 12, 10:39AM CST

IYH: 149.63 (+0.84), PSCH: 63.77 (+0.26), FHLC: 34.19 (+0.16), IXJ: 104.21 (+0.61), VHT: 130.56 (+0.66), FXH: 62.97 (+0.34), XLV: 70.72 (+0.28)

Connecture on deck for IPO
Seeking Alpha - at Seeking Alpha - Fri Dec 05, 11:18AM CST

IPO: 24.00 (+0.09), IXJ: 104.21 (+0.61), IRY: 49.63 (+0.34)

Hydration could save many Ebola victims
Seeking Alpha - at Seeking Alpha - Fri Dec 05, 6:19AM CST

JNJ: 99.62 (+1.18), BCRX: 10.06 (-0.09), HEB: 0.25 (+0.01), SRPT: 12.76 (+0.11), MRK: 58.81 (-0.07), NLNK: 38.84 (+1.51), TKMR: 21.45 (-0.22), GSK: 47.94 (+1.99), IXJ: 104.21 (+0.61), IRY: 49.63 (+0.34)

Hospitals save lives by making fewer mistakes
Seeking Alpha - at Seeking Alpha - Tue Dec 02, 9:22AM CST

SSY: 1.39 (+0.06), HCA: 68.54 (-0.48), LPNT: 69.04 (-0.06), CYH: 48.14 (+0.92), UHS: 104.93 (+0.84), SEM: 14.32 (+0.11), IXJ: 104.21 (+0.61), IRY: 49.63 (+0.34), HUM: 152.67 (-1.06)

Vargatef cleared in Europe for lung cancer
Seeking Alpha - at Seeking Alpha - Fri Nov 28, 8:23AM CST

HTBX: 5.83 (+0.22), BIB: 141.30 (+2.39), INCY: 75.94 (+0.28), PFE: 34.64 (-0.23), IBB: 323.46 (+3.04), DRGS: 56.69 (unch), BIND: 6.06 (+0.21), BMY: 60.04 (+0.56), GSK: 47.94 (+1.99), ONTY: 1.57 (unch), ECYT: 5.26 (-0.02), BIS: 39.67 (-0.75), CLVS: 68.79 (+0.71), AZN: 69.96 (+0.20), MRK: 58.81 (-0.07), ARIA: 7.35 (+0.45), IRY: 49.63 (+0.34), IXJ: 104.21 (+0.61), FPRX: 24.63 (+0.63)

Drug makers face pushback on pricey meds
Seeking Alpha - at Seeking Alpha - Tue Nov 25, 7:18AM CST

ABT: 46.09 (+0.87), BIIB: 391.66 (-0.45), BIB: 141.30 (+2.39), PFE: 34.64 (-0.23), AMGN: 153.48 (+0.30), IBB: 323.46 (+3.04), LLY: 70.56 (+0.03), DRGS: 56.69 (unch), GSK: 47.94 (+1.99), BMY: 60.04 (+0.56), CELG: 115.88 (+0.16), JNJ: 99.62 (+1.18), ESRX: 84.90 (+0.40), BIS: 39.67 (-0.75), MRK: 58.81 (-0.07), AZN: 69.96 (+0.20), CVS: 102.63 (-0.37), ABBV: 58.05 (+1.00), SNY: 49.42 (+0.82), IRY: 49.63 (+0.34), IXJ: 104.21 (+0.61), NVS: 102.20 (-0.17)

CB Pharma on deck for IPO
Seeking Alpha - at Seeking Alpha - Fri Nov 21, 10:46AM CST

IPO: 24.00 (+0.09), BIS: 39.67 (-0.75), BIB: 141.30 (+2.39), CNDO: 2.28 (+0.03), IBB: 323.46 (+3.04), DRGS: 56.69 (unch), IXJ: 104.21 (+0.61), IRY: 49.63 (+0.34)

CF Foundation sells royalties for $3.3B
Seeking Alpha - at Seeking Alpha - Thu Nov 20, 7:03AM CST

BIS: 39.67 (-0.75), VRTX: 113.66 (+4.03), BIB: 141.30 (+2.39), IBB: 323.46 (+3.04), DRGS: 56.69 (unch), IXJ: 104.21 (+0.61), IRY: 49.63 (+0.34)

Global drug tab will breach trillion dollar mark this year
Seeking Alpha - at Seeking Alpha - Thu Nov 20, 6:41AM CST

BIS: 39.67 (-0.75), IMS: 25.68 (+0.22), PCYC: 163.28 (+0.23), GILD: 101.90 (+1.10), BIB: 141.30 (+2.39), IBB: 323.46 (+3.04), AMGN: 153.48 (+0.30), DRGS: 56.69 (unch), IXJ: 104.21 (+0.61), IRY: 49.63 (+0.34)

Inside The New Global Momentum ETF From Cambria
Zacks Funds - at Seeking Alpha - Tue Nov 18, 10:12PM CST
Originally published November 12. Los Angeles-based Cambria, with a keen eye on launching funds based on the global markets with a risk management touch, has recently come up with a new fund. The newly launched product – Cambria Global...
MMTM: 88.54 (+0.08), GMOM: 25.64 (-0.07), MTUM: 70.13 (+0.09), EFFE: 26.38 (-0.06), PDP: 42.52 (+0.28), FM: 30.23 (+0.32), FV: 23.10 (+0.17), IXJ: 104.21 (+0.61)

Stock Investors Make Up New Rules For Their New Market Paradigm
Scott Martindale - Seeking Alpha - Tue Nov 18, 12:49PM CST
Investors in U.S. equities seem to have embraced a new market paradigm in which upside spikes come more swiftly than the downside selloffs. Remember when it used to be the other way around? When fear was stronger than greed? The market is...
XTN: 106.48 (+0.70), PSI: 26.30 (-0.18), SPY: 209.78 (+0.86), IXJ: 104.21 (+0.61)

PRA Health Sciences on deck for IPO
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 1:06PM CST

IPO: 24.00 (+0.09), BIS: 39.67 (-0.75), BIB: 141.30 (+2.39), IBB: 323.46 (+3.04), DRGS: 56.69 (unch), PRAH: 27.19 (+0.31), IXJ: 104.21 (+0.61), IRY: 49.63 (+0.34)

Obama appoints Ebola czar
Seeking Alpha - at Seeking Alpha - Fri Oct 17, 12:35PM CDT

BCRX: 10.06 (-0.09), VSR: 3.42 (-0.02), TKMR: 21.45 (-0.22), NNVC: 2.97 (-0.05), INO: 6.80 (-0.15), CMRX: 40.16 (+0.08), APT: 2.88 (+0.17), HEB: 0.25 (+0.01), SRPT: 12.76 (+0.11), SMED: 4.75 (-0.04), NLNK: 38.84 (+1.51), PLX: 1.84 (-0.04), LAKE: 10.18 (+0.89), IXJ: 104.21 (+0.61), IRY: 49.63 (+0.34), NSPH: 0.25 (unch)

Feds examine what went wrong at Texas hospital where two nurses infected with Ebola
Seeking Alpha - at Seeking Alpha - Thu Oct 16, 7:46AM CDT

BIS: 39.67 (-0.75), BIB: 141.30 (+2.39), IBB: 323.46 (+3.04), DRGS: 56.69 (unch), IXJ: 104.21 (+0.61), IRY: 49.63 (+0.34)

IXJ Crowded With Sellers
ETFChannel.com - Wed Oct 15, 10:01AM CDT
In trading on Wednesday, shares of the iShares Global Healthcare ETF entered into oversold territory, changing hands as low as $90.22 per share. We define oversold territory using the Relative Strength Index, or RSI, which is a technical analysis...
IXJ: 104.21 (+0.61)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Shell Lowers Q4 LNG Production Projections and Outlook

Updated Category News Views 165

Shell Adjusts Q4 LNG Production Forecast Recently, Shell announced an adjustment to its liquefied natural gas (LNG) production outlook for the fourth quarter. The changes reflect updated expectations following market conditions and internal assessments. Revised LNG Production Estimates Shell now anticipates its LNG production for the quarter to fall within the range of...

Continue Reading
BioCryst Sells European ORLADEYO Business for $264 Million

Updated Category News Views 255

Major Transaction Announcement BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) recently shared exciting news, revealing their decision to sell the European segment of their ORLADEYO® (berotralstat) business to Neopharmed Gentili. This strategic move is valued at up to $264 million, comprising a notable upfront payment of $250 million. The deal aligns perfectly with...

Continue Reading
Community Engagement Takes Center Stage at SAS Championship

Updated Category News Views 156

Community Engagement Takes Center Stage at SAS Championship Community initiative supports local teachers, sparks student interest in technology Teachers often face financial challenges covering classroom needs, especially in STEM (science, technology, engineering, and math) education, which is critical for preparing students for a tech-driven future. To alleviate this,...

Continue Reading
Lexar Introduces Cutting-Edge SSDs for Gamers and Creatives

Updated Category News Views 299

Lexar Unveils New PCIe 4.0 and PCIe 5.0 SSDs In a significant move for gamers and creative professionals, Lexar has introduced its latest line of SSDs aimed at elevating gameplay and enhancing professional applications. The new products come equipped with groundbreaking technology that accelerates performance and minimizes load times. Key Features of the NM1090 PRO PCIe...

Continue Reading
Explore Sakrete and Amerimix's Innovations at Concrete Event

Updated Category News Views 303

Get Ready for the World of Concrete Experience Sakrete, the leading bagged concrete materials brand, along with Amerimix, known for its pre-blended mortars and grouts, is preparing for an exciting showcase of their latest innovations at the World of Concrete event in Las Vegas. Visitors can anticipate a fully immersive experience at their booth, where the brands will...

Continue Reading